FLUCORTAC 50 microgrammes

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire De Nantes, H.A.C. Pharma

Conditions

Neurogenic Orthostatic Hypotensionacute myeloid leukemia

Phase 3

FLUCLORIC - Randomized multicentric Phase III study comparing the efficacy of two reduced intensity conditioning regimens (clofarabine/busulfan versus fludarabine/busulfan) in adults with acute myeloid leukemia and eligible to allogeneic stem cell transplantation: a SFGM-TC study

RecruitingCTIS2022-502019-12-00

Centre Hospitalier Universitaire De Nantesacute myeloid leukemia

Start: 2023-09-14Target: 302Updated: 2024-11-29

Phase 4

Evaluation of efficacy and tolerance of fludrocortisone (Flucortac) in the treatment of neurogenic orthostatic hypotension

RecruitingCTIS2024-517841-16-00

H.A.C. PharmaNeurogenic Orthostatic Hypotension

Start: 2020-07-09Target: 90Updated: 2024-10-29